Invitae Invitae Publishes First Validation Data on MRD Assays, Laying Path to Future Clinical Expansion Premium The analytical validity study is the first published featuring full performance data for the firm's Personalized Cancer Monitoring technology. People in the News at NanoString, Invitae, Telesis Bio, Biocartis, Delve Bio, Co-Diagnostics Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Aug. 28, 2023. People in the News at Halo Precision Diagnostics, Invitae, Bionano Genomics, More Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Aug. 14, 2023. Invitae Q2 Revenues Fall 12 Percent as Firm Lowers Full-Year Guidance Revenue grew about 1 percent on a pro forma basis after removing about $17.5 million from Q2 2022 revenues that were related to discontinued businesses and geographies. People in the News at Invitae, Theralink Technologies, Camena Bioscience Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of July 3, 2023 Jun 1, 2023 GenomeWeb Top 40 Falls 7 Percent in May As Broader Market Delivers Mixed Results May 26, 2023 People in the News at Invitae, Cepheid, Nucleai, Angle, Quantum-Si, Twist Bioscience May 15, 2023 Jury Awards Natera $19.4M in Damages in Invitae, ArcherDx Patent Infringement Suit May 9, 2023 Invitae Revenues Decline 5 Percent in Q1 After Company Exits Businesses, Geographies May 5, 2023 Tesis Biosciences Prepping 'One-Stop Shop' Pharmacogenomics Panel Aimed at Consumers Premium Apr 3, 2023 GenomeWeb Top 40 Rises 3 Percent in March, Following Broader Market Mar 22, 2023 Invitae, Deerfield Management Partner to Mine Test Data for Rare Disease Drug Development Mar 21, 2023 Invitae, Epic Sign Deal to Integrate Genetic Test Results Into EMR System Mar 17, 2023 People in the News at Invitae, Resolve Biosciences, 54gene, Arima Genomics, Accelerate Diagnostics Mar 6, 2023 Invitae's PCM Assay for Minimal Residual Disease Detection Nabs Coverage by Blue Shield of California Mar 1, 2023 Invitae Refinances Debt, Raises $30M as Q4 Revenues Drop 3 Percent Feb 27, 2023 UnitedHealthcare Clamping Down on Expanded Carrier Screening, Genetic Counselors, Testing Firms Say Premium Jan 19, 2023 Invitae Bets on Oncology Portfolio to Drive Growth as it Streamlines, Integrates Test Services Premium Jan 12, 2023 JP Morgan Healthcare Conference, Day 3: Invitae, NanoString, Bio-Rad, Olink, More Jan 9, 2023 Invitae Preliminary Q4 Revenues in Line With Wall Street Estimate Jan 4, 2023 Losses Deep and Widespread as GenomeWeb Top 40 Drops 34 Percent in 2022 Jan 3, 2023 GenomeWeb Top 40 Down 3 Percent in December, Though More Resilient Than Broader Market Dec 30, 2022 Top 10 Articles on GenomeWeb in 2022: Illumina, Invitae, 10x Genomics, Natera, Element, Ultima, More Dec 21, 2022 Genomics Firms Tackle Carbon Emissions, Face Obstacles to Net-Zero Goals From Suppliers, Shipping Premium Dec 20, 2022 Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M Load More Breaking News GA4GH Announces 10 New 'Driver' Projects, Including First Pediatric Partner Single-Cell MRD Assay Helps Characterize Cells Surviving Acute Myeloid Leukemia Therapy Research Triangle Institute Partners With GeneDx, Illumina for Expanded Newborn Screening Study Bionano Genomics' Third Chinese OEM Partner Gets NMPA Nod for Sample Prep Product InformedDNA Buys gWell Health, Names New CEO The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.